83 Results

People

  1. Kris
    Kris
  2. Chou
    Chou
  3. Fair
    Fair
  4. Motzer
    Motzer
  5. O'Reilly
    O'Reilly
  6. Rabbani
    Rabbani
  7. Bastar
    Bastar
  8. Fong
    Fong
  9. Hellmann
    Hellmann
  10. Morris
    Morris

Groups

  1. Department of Medicine (53)
  2. Solid Tumor Oncology Division (49)
  3. Genitourinary Oncology Service (14)
  4. Thoracic Oncology (13)
  5. Sloan Kettering Institute Postdocs (10)
  6. Surgery (10)
  7. Breast Medicine Service (9)
  8. Center for Pancreatic Cancer Research (9)
  9. GSK Faculty (9)
  10. Epidemiology and Biostatistics (8)
  1. "combination"
Formats
  1. Journal Article (69)
  2. Review (7)
  3. Conference Paper (3)
  4. Book Section (2)
  5. Editorial (1)
  6. Meeting Abstract (1)
Groups
  1. Department of Medicine (53)
  2. Solid Tumor Oncology Division (49)
  3. Genitourinary Oncology Service (14)
  4. Thoracic Oncology (13)
  5. Sloan Kettering Institute Postdocs (10)
  6. Surgery (10)

More Groups

People
  1. Ting-Chao Chou (6)
  2. Mark Kris (5)
  3. Eileen O'Reilly (4)
  4. Farhang Rabbani (4)
  5. Robert Motzer (4)
  6. William Fair (4)

More People

Years
  1. 2025 (2)
  2. 2024 (1)
  3. 2023 (6)
  4. 2022 (3)
  5. 2021 (6)
  6. 2020 (9)

More Years

Publications
  1. Journal of Clinical Oncology (17)
  2. Journal for ImmunoTherapy of Cancer (5)
  3. Annals of Oncology (3)
  4. Clinical Cancer Research (3)
  5. Molecular Urology (3)
  6. Seminars in Oncology (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (19)
  2. Elsevier Inc. (8)
  3. Oxford University Press (6)
  4. American Association for Cancer Research (5)
  5. Biomed Central Ltd (5)
  6. Elsevier Science, Inc. (4)

More Publishers

Results (83)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase III trial evaluating letrozole as first-line endocrine therapy with or without bevacizumab for the treatment of postmenopausal women with hormone receptor-positive advanced-stage breast cancer: CALGB 40503 (Alliance)
    Journal Article

    Dickler, M. N.; Barry, W. T.; Cirrincione, C. T.; Ellis, M. J.; Moynahan, M. E.; Innocenti, F.; Hurria, A.; Rugo, H. S.; Lake, D. E.; Hahn, O.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Bendamustine plus rituximab versus R-CHOP as first-line treatment for patients with indolent non-Hodgkin's lymphoma: evidence from a multicenter, retrospective study
    Journal Article

    Mondello, P.; Steiner, N.; Willenbacher, W.; Wasle, I.; Zaja, F.; Zambello, R.; Visentin, A.; Mauro, E.; Ferrero, S.; Ghione, P.; more...
    Annals of Hematology (2016)

    Fulltext@MSK | Save
  • Updated long-term survival for patients with metastatic colorectal cancer treated with liver resection followed by hepatic arterial infusion and systemic chemotherapy
    Journal Article

    Kemeny, N. E.; Chou, J. F.; Boucher, T. M.; Capanu, M.; DeMatteo, R. P.; Jarnagin, W. R.; Allen, P. J.; Fong, Y.; Cercek, A.; D'Angelica, M. I.
    Journal of Surgical Oncology (2016)

    Fulltext@MSK | Save
  • Phase I/II trial of vorinostat with rituximab, cyclophosphamide, etoposide and prednisone as palliative treatment for elderly patients with relapsed or refractory diffuse large B-cell lymphoma not eligible for autologous stem cell transplantation
    Journal Article

    Straus, D. J.; Hamlin, P. A.; Matasar, M. J.; Lia Palomba, M.; Drullinsky, P. R.; Zelenetz, A. D.; Gerecitano, J. F.; Noy, A.; Hamilton, A. M.; Elstrom, R.; more...
    British Journal of Haematology (2015)

    Fulltext@MSK | Save
  • Immune modulation for cancer therapy
    Journal Article

    Naidoo, J.; Page, D. B.; Wolchok, J. D.
    British Journal of Cancer (2014)

    Fulltext@MSK | Save
  • ATLAS: Randomized, double-blind, placebo-controlled, phase IIIB trial comparing bevacizumab therapy with or without erlotinib, after completion of chemotherapy, with bevacizumab for first-line treatment of advanced non-small-cell lung cancer
    Journal Article

    Johnson, B. E.; Kabbinavar, F.; Fehrenbacher, L.; Hainsworth, J.; Kasubhai, S.; Kressel, B.; Lin, C. Y.; Marsland, T.; Patel, T.; Polikoff, J.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Disease course patterns after discontinuation of bevacizumab: Pooled analysis of randomized phase III trials
    Journal Article

    Miles, D.; Harbeck, N.; Escudier, B.; Hurwitz, H.; Saltz, L.; Van Cutsem, E.; Cassidy, J.; Mueller, B.; SirzeĢn, F.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Phase III study comparing gemcitabine plus cetuximab versus gemcitabine in patients with advanced pancreatic adenocarcinoma: Southwest Oncology Group-directed intergroup trial S0205
    Journal Article

    Philip, P. A.; Benedetti, J.; Corless, C. L.; Wong, R.; O'Reilly, E. M.; Flynn, P. J.; Rowland, K. M.; Atkins, J. N.; Mirtsching, B. C.; Rivkin, S. E.; more...
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: Phase III trial of the Cancer and Leukemia Group B (CALGB 80303)
    Journal Article

    Kindler, H. L.; Niedzwiecki, D.; Hollis, D.; Sutherland, S.; Schrag, D.; Hurwitz, H.; Innocenti, F.; Mulcahy, M. F.; O'reilly, E.; Wozniak, T. F.; more...
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Synergistic action of oncolytic herpes simplex virus and radiotherapy in pancreatic cancer cell lines
    Journal Article

    Dai, M. H.; Zamarin, D.; Gao, S. P.; Chou, T. C.; Gonzalez, L.; Lin, S. F.; Fong, Y.
    British Journal of Surgery (2010)

    Fulltext@MSK | Save